The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Lilly; Novartis; Pfizer; Roche
Speakers' Bureau - AstraZeneca; Lilly; Merck Sharp & Dohme
Research Funding - Agendia; Daiichi Sankyo; Gilead Sciences; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
Other Relationship - Initia-Research; MedSIR
Patritumab deruxtecan (HER3-DXd) in active brain metastases from metastatic breast and non-small cell lung cancers, and leptomeningeal disease from advanced solid tumors: The TUXEDO-3 phase II trial.
 
Rupert Bartsch
Honoraria - AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo; Eisai; Lilly
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Eisai; Lilly
Research Funding - Daiichi Sankyo
Travel, Accommodations, Expenses - Daiichi Sankyo; MDS Foundation; Novartis; Pfizer
 
Marta Vaz Batista
Honoraria - AstraZeneca; Daiichi Sankyo; GlaxoSmithKline
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo
Speakers' Bureau - Novartis
Travel, Accommodations, Expenses - AstraZeneca
 
Anna Sophie Berghoff
No Relationships to Disclose
 
Julia Furtner
Consulting or Advisory Role - Novartis; Seagen
Speakers' Bureau - SanovaWorks; Seagen
 
Maximilian Marhold
Consulting or Advisory Role - Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer
Speakers' Bureau - Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis; Pfizer
Research Funding - Daiichi Sankyo
Travel, Accommodations, Expenses - Daiichi Sankyo; Gilead Sciences; Lilly; MSD; Novartis
 
Felicitas Oberndorfer
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - Merck Sharp & Dohme
 
Javier Garde
No Relationships to Disclose
 
Manuel Ruiz-Borrego
Honoraria - Novartis; pfizer; Roche/Genentech
Consulting or Advisory Role - Puma Biotechnology; Roche
 
Richard Greil
Stock and Other Ownership Interests - Lilly (Inst); Novo Nordisk (Inst)
Honoraria - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Merck; MSD; Novartis; Roche; Sandoz; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen; Merck; MSD; Novartis; Roche; Sanofi; Takeda
Research Funding - Abbvie; Abbvie; Amgen (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo Europe GmbH (Inst); Gilead Sciences (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Roche (Inst); Sandoz (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Abbvie; Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Daiichi Sankyo; Gilead Sciences; Janssen-Cilag; MSD; Novartis; Roche
 
Giulia Raimondi
No Relationships to Disclose
 
Marta Campolier
No Relationships to Disclose
 
Carlos Jiménez-Cortegana
Other Relationship - Employee at MedSIR
 
Paula González-Alonso
No Relationships to Disclose
 
Miguel Sampayo-Cordero
Other Relationship - Employee at MedSIR
 
Antonio Llombart
No Relationships to Disclose
 
Thorsten Fuereder
Honoraria - Amgen; Boehringer Ingelheim; Bristol-Myers Squibb/Celgene; Merck KGaA; MSD; Pfizer; Roche
Consulting or Advisory Role - Amgen; Boehringer Ingelheim; Invios; Invios; Janssen; Lilly; Merck KGaA; MSD; Takeda
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Kura Oncology (Inst); Merck KGaA (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Celgene; Merck KGaA; MSD
 
Matthias Preusser
Honoraria - Abbvie; Adastra Pharmaceuticals; AstraZeneca; Bayer; BMJ Journals; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Medahead; MedMedia; Merck Sharp & Dome; Mundipharma; Novartis; Roche; Sanofi; SERVIER; Tocagen
Consulting or Advisory Role - AbbVie; Adastra Pharmaceuticals; AstraZeneca; Bayer; Bristol-Myers Squibb; CMC Contrast; Daiichi Sankyo/Astra Zeneca; Gan & Lee; Gerson Lehrman Group; GlaxoSmithKline; Lilly; Merck Sharp & Dome; Mundipharma; Novartis; Roche; Sanofi; SERVIER; Tocagen
Research Funding - AbbVie (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); GlaxoSmithKline (Inst); Merck Sharp & Dohme; Roche (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Mundipharma; Roche; SERVIER